MedPath

A cluster randomised controlled trial of an occupational therapy intervention for residents with stroke living in UK care-homes

Phase 3
Completed
Conditions
Stroke rehabilitation
Circulatory System
Stroke, not specified as haemorrhage or infarction
Registration Number
ISRCTN00757750
Lead Sponsor
niversity of Birmingham (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
840
Inclusion Criteria

Adult men and women living in a care home with a history of stroke or transient ischaemic attack (TIA)

Exclusion Criteria

Active end of life care plan

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Independence in activities of daily living, assessed using the Barthel Activity of Daily Living Index, a commonly used measure (toileting, dressing, feeding, continence, mobility and grooming) containing 10 items and scored from 0-20 (with 20 being more independent)<br> <br>All primary and secondary outcome measures will be assessed at baseline (0 months), after the intervention (3 months) and at follow-up (6 and 12 months).
Secondary Outcome Measures
NameTimeMethod
1. Rivermead Mobility Index (RMI), a 15 item measure of functional mobility (scored 0-15, 15 being more mobile)<br>2. Mood, assessed by a 15-item Geriatric Depression Scale (GDS15), and informant version<br>3. Adverse events<br>4. Staff attitude<br>5. Health utility will be estimated using the Euroqol EQ-5D <br> <br>All primary and secondary outcome measures will be assessed at baseline (0 months), after the intervention (3 months) and at follow-up (6 and 12 months). <br> <br>In addition, the Mini-Mental State Examination (MMSE) will be used at baseline to determine the level of a resident's cognitive impairment; not as an exclusion criterion.
© Copyright 2025. All Rights Reserved by MedPath